One article interpretation: 2022 NCCN V1 pathological diagnosis requirements for colon cancer guidelines

*For medical professionals for reading reference

Last time was the European Guide, this time I read the US Guide!

In clinical work, pathologists often refer to the World Health Organization (WHO)/International Cancer Research Agency (IARC) tumor classification to study tumors. Clinicians are more commonly used in the US National Comprehensive Cancer Network (NCCN) Guide, European Tumor Internal Science (ESMO) (ESMO)Guidelines, China Clinical Oncology Society (CSCO) Guide, etc., diagnose and treat tumor patients.

The former focuses on the form, formation, and molecular genetic of the tumor; the latter's demand for pathological diagnosis is more focused on clinical applications. This difference is often reflected in the usual multidisciplinary group (MDT) consultation.Therefore, familiarity with the pathological requirements in clinical tumor guidelines can help improve the clinical thinking of pathologists and promote communication and understanding between pathology and clinical.

This article focuses on the latest version of NCCN Guidelines Version 1.2022 Colon Cancer, HTTPS: //www.nccn.org/guidelines/).

Scan the QR code below to get more tumor cutting -edge information

- END -